Dr. Gore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13123 E 16th Ave
Box B115 CCBD
Aurora, CO 80045Phone+1 720-777-6458Fax+1 720-777-7339- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Pediatric Hematology/Oncology, 1996 - 2001
- University of ColoradoResidency, Pediatrics, 1994 - 1996
- Children's National Medical CenterInternship, Pediatrics, 1993 - 1994
- George Washington University School of Medicine and Health SciencesClass of 1993
- Carleton CollegeB.A., Psychology, 1987
Certifications & Licensure
- CO State Medical License 1995 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Docs Award 5280 Magazine, 2012, 2014-2020
- Regional Top Doctor Castle Connolly, 2014
- Disruptive Innovators in Research Excellence University of Colorado School of Medicine, 2013
- Join now to see all
Clinical Trials
- Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Jan 01
- Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors Start of enrollment: 2005 Sep 01
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsINSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.Adam J Lamble, Amy Moskop, Michael A Pulsipher, Shannon L Maude, Corinne Summers, Colleen Annesley, André Baruchel, Lia Gore, Persis Amrolia, Nirali Shah> ;Transplantation and Cellular Therapy. 2023 Nov 1
- 4 citationsLow leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.Manon Queudeville, Anthony S Stein, Franco Locatelli, Martin Ebinger, Rupert Handgretinger, Nicola Gökbuget, Lia Gore, Yi Zeng, Priya Gokani, Gerhard Zugmaier, Hagop M...> ;Cancer. 2023 May 1
- 5 citationsPhase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia.Michael J Burke, David S Ziegler, Francisco Bautista, Andishe Attarbaschi, Lia Gore, Franco Locatelli, Maureen M O'Brien, Melinda Pauly, William N Kormany, Shengqi Tia...> ;Pediatric Blood & Cancer. 2022 Dec 1
- Join now to see all
Journal Articles
- Phase I Combination Study of Trabectedin and Capecitabine in Patients With Advanced MalignanciesGore L, Rivera E, Basche M, Moulder SL, LaVallee K, Li J, Sarah Eppers S, Grolnic S, O'Bryant CL, Cleere D, Elsayed YA, Eckhardt SG, Investigational New Drugs, 1/1/2011
- A phase I study of weekly R1507 - a human monoclonal antibody insulin-like growth factor receptor-1 antagonist - in patients with advanced solid tumorsKurzrock R, Mitta AC, Ainser J, Eid JE, Greig G, Habben K, McCarthy CD, Eckhardt SG, Gore L, Clinical Cancer Research, 1/6/2010
- Challenges and Controversies in Early-phase Pediatric Oncology Clinical Trials: Who, How, Why, and What ?Gore L and Eckhardt SG, ASCO News and Forum, 1/1/2009
- Join now to see all
Abstracts/Posters
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Lia Gore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...Lia Gore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid...Lia Gore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Expanding Horizons for Immunotherapy in Pediatric Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Podcast: CU Anschutz Powers up for Regenerative Medicine FrontierMay 9th, 2023
- Rubio, Bennet Introduce Bill to Boost Pediatric Cancer Research Through Combination Drug TrialsMay 13th, 2022
- CU Cancer Members Recognized for Contributions to Immunotherapy in Pediatric CancerJune 23rd, 2021
- Join now to see all
Grant Support
- COG NCTN Network Group Operations CenterNational Cancer Institute2019–2025
- Agent Prioritization CommitteeNational Cancer Institute2018–2023
- Cancer Center Support Grant, Senior LeadersNational Cancer Institute1997–2022
- Eliminating Disparities in Patients with Acute LeukemiasUniversity of Colorado Cancer Center2020–2021
Professional Memberships
- Member
- Member
- Member
- American Society of Pediatric Hematology/OncologyMember
- Children's Oncology GroupMember
Hospital Affiliations
- University of Colorado HospitalAurora, Colorado
- Children's Hospital ColoradoAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: